Product image of Gynokadin (Estradiol Valerate) supplied by GNH India

Gynokadin

Active Ingredient:
Estradiol Valerate
Origin:
EU

Gynokadin (Estradiol Valerate)

Gynokadin is a prescription oral medication that contains the estrogen estradiol valerate as its active ingredient; the product is supplied in tablet form (strength not specified) and is marketed in the European Union for hormone replacement therapy. It belongs to the estrogen drug class and works by binding to estrogen receptors, providing systemic estrogenic activity to address deficiency states, primarily in women experiencing menopausal changes.

Manufacturer / TM Owner

Besins Healthcare Germany Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Gynokadin is indicated for the management of conditions associated with low estrogen levels.

  • Relief of moderate to severe vasomotor symptoms such as hot flashes and night sweats associated with menopause.
  • Treatment of genitourinary atrophy causing vaginal dryness, irritation, or dyspareunia.
  • Prevention of bone loss and reduction of fracture risk in post‑menopausal women.
  • Management of estrogen deficiency following oophorectomy or hypogonadism.
  • Adjunct therapy in hormone replacement regimens for women with premature ovarian insufficiency.

Side Effects

Side effects reported with oral estradiol valerate vary in frequency and severity.

Common

  • Nausea or mild gastrointestinal upset.
  • Breast tenderness or enlargement.
  • Headache or mild dizziness.
  • Fluid retention leading to mild edema.

Serious

  • Deep vein thrombosis or pulmonary embolism.
  • Stroke or transient ischemic attack.
  • Endometrial hyperplasia or carcinoma in women with an intact uterus.

Precautions & Warnings

Before initiating Gynokadin, clinicians should evaluate several safety considerations.

  • History of thromboembolic disease, stroke, or myocardial infarction.
  • Known or suspected estrogen‑dependent neoplasms, such as breast or endometrial cancer.
  • Undiagnosed vaginal bleeding or abnormal uterine bleeding.
  • Active liver disease or severe hepatic impairment.
  • Pregnancy, lactation, or intention to become pregnant.
  • Smoking, especially in women over 35 years of age.
  • Uncontrolled hypertension or diabetes.

Avoid Interactions

Estradiol valerate can interact with a range of medications, affecting efficacy or safety.

Avoid

  • Combined oral contraceptives or other estrogen‑containing products, which increase risk of thrombosis.
  • Anticoagulants such as warfarin, where estrogen may enhance anticoagulant effect.
  • Certain anticonvulsants (e.g., carbamazepine, phenytoin) that induce hepatic enzymes and lower estradiol levels.

Use with caution

  • Selective serotonin reuptake inhibitors (SSRIs) that may increase risk of hyponatremia.
  • Thyroid hormone replacement, as estrogen can raise thyroid‑binding globulin.
  • Antifungal agents like ketoconazole that inhibit steroid metabolism.

Frequently Asked Questions

Gynokadin contains estradiol valerate, which is converted to estradiol in the body and binds to estrogen receptors, activating estrogen‑dependent gene transcription and producing systemic estrogenic effects.

By supplying estrogen, Gynokadin compensates for the decline in endogenous hormone levels that trigger vasomotor instability, thereby reducing the frequency and severity of hot flashes.

Yes, estrogen therapy, including estradiol valerate, can help maintain bone mineral density and lower fracture risk when used as part of a comprehensive osteoporosis prevention strategy.

Common adverse effects include nausea, mild gastrointestinal upset, breast tenderness, headache, dizziness, and mild fluid retention leading to peripheral edema.

Gynokadin should be avoided in women with a history of thromboembolic events, estrogen‑dependent cancers, undiagnosed vaginal bleeding, severe liver disease, or who are pregnant or breastfeeding.

Smoking increases the risk of cardiovascular and thromboembolic complications associated with estrogen therapy, so women who smoke, especially over age 35, should be cautioned or advised to quit before using Gynokadin.

No specific dietary restrictions are required, but patients should maintain a balanced diet and discuss any herbal supplements or high‑fat meals with their healthcare provider, as they may affect hormone metabolism.

Estrogen can potentiate the effect of anticoagulants, so concurrent use with warfarin or similar agents should be closely monitored and dose adjustments may be necessary.

Regular follow‑up should include blood pressure checks, lipid profile, liver function tests, and, for women with a uterus, periodic gynecologic examinations to assess endometrial health.

Enzyme‑inducing anticonvulsants such as carbamazepine or phenytoin can increase the metabolism of estradiol, potentially reducing its therapeutic effect; dose adjustments or alternative therapies may be needed.

Women without a uterus have a lower risk of endometrial hyperplasia, but they should still be evaluated for other estrogen‑related risks before starting therapy.

If a dose is missed, take it as soon as remembered unless it is close to the time of the next scheduled dose; do not double‑dose. Consult a healthcare professional for personalized guidance.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Estradiol Valerate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT